[ad_1] SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ — Daewoong Pharmaceutical (KRX: 069620.KS) is pleased to announce its financial results for the third quarter of 2023. Demonstrating a consistent growth…
[ad_1] SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ — Daewoong Pharmaceutical (KRX: 069620.KS) is pleased to announce its financial results for the third quarter of 2023. Demonstrating a consistent growth…